Tetiana P. Perekhrestenko

Kapitanivka, 08112, Ukraine

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Incidence, molecular and clinical characteristics of donor-derived hematologic malignancies after allogeneic stem cell transplantation for myeloid malignancies.

Incidence, molecular and clinical characteristics of donor-derived hematologic malignancies after allogeneic stem cell transplantation for myeloid malignancies.

Journal: Haematologica
Published: April 20, 2026

Erratum to: "Lower incidence of chronic graft-versus-host disease after ruxolitinib plus extracorporeal photopheresis versus ruxolitinib alone in steroid-refractory acute graft-versus-host disease following allogeneic stem cell transplantation".

Erratum to: "Lower incidence of chronic graft-versus-host disease after ruxolitinib plus extracorporeal photopheresis versus ruxolitinib alone in steroid-refractory acute graft-versus-host disease following allogeneic stem cell transplantation".

Journal: Haematologica
Published: March 01, 2026

Safety, tolerability, and pharmacokinetics of lisaftoclax (APG-2575)-based therapy in patients with chronic lymphocytic leukemia: Phase 1b/2 study.

Safety, tolerability, and pharmacokinetics of lisaftoclax (APG-2575)-based therapy in patients with chronic lymphocytic leukemia: Phase 1b/2 study.

Journal: Med (New York, N.Y.)
Published: April 16, 2025

Sequential versus standard conditioning in untreated MDS patients with blasts undergoing allogeneic HSCT.

Sequential versus standard conditioning in untreated MDS patients with blasts undergoing allogeneic HSCT.

Journal: Bone marrow transplantation
Published: March 25, 2025

Lower incidence of chronic graft-versus-host disease after ruxolitinib plus extracorporeal photopheresis versus ruxolitinib alone in steroid-refractory acute graft-versus-host disease following allogeneic stem cell transplantation.

Lower incidence of chronic graft-versus-host disease after ruxolitinib plus extracorporeal photopheresis versus ruxolitinib alone in steroid-refractory acute graft-versus-host disease following allogeneic stem cell transplantation.

Journal: Haematologica
Published: November 06, 2024

Comparable Results Between 8 and 12 Gray TBI in Combination With Fludarabine and Post-Transplant Cyclophosphamide in MRD-Negative but Not in MRD-Positive Acute Lymphoblastic Leukemia Patients Transplanted in First Complete Remission.

Comparable Results Between 8 and 12 Gray TBI in Combination With Fludarabine and Post-Transplant Cyclophosphamide in MRD-Negative but Not in MRD-Positive Acute Lymphoblastic Leukemia Patients Transplanted in First Complete Remission.

Journal: European journal of haematology
Published: June 08, 2024

Expression of Ki-67 and CD34 on blood and bone marrow cells of CML patients with different response to imatinib and nilotinib therapy.

Expression of Ki-67 and CD34 on blood and bone marrow cells of CML patients with different response to imatinib and nilotinib therapy.

Journal: Experimental oncology
Published: July 01, 2020

Mechanisms of resistance in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.

Mechanisms of resistance in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.

Journal: Georgian medical news
Published: April 17, 2015

Functional activity of CD34-positive cells in chronic myeloid leukemia patients with different response to imatinib therapy.

Functional activity of CD34-positive cells in chronic myeloid leukemia patients with different response to imatinib therapy.

Journal: Experimental oncology
Published: March 26, 2015

Determination of the optimal chemotherapy drugs pretreatment time through cultivation of hemopoietic cells in CML-patients treated with tyrosine kinase inhibitors.

Determination of the optimal chemotherapy drugs pretreatment time through cultivation of hemopoietic cells in CML-patients treated with tyrosine kinase inhibitors.

Journal: Experimental oncology
Published: July 02, 2014
Showing 1-10 of 10

Last Updated: 09/26/2026